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Abstract
Despite the fact that the low- and middle-income countries that are most affected by the Non-communicable diseases
have a net capital inflows-to-GDP ratio that represents a significant part of the investment rate, the existing models
that quantify the economic burden of disease do not account for the fact that the diseases affect the nets capital
inflows-to-GDP ratio. This paper proposes a framework for the analysis of the macroeconomic impact of non-
communicable diseases, building upon a Solow-style model. It additionally accounts for i) the fact that the diseases
affect the nets capital inflows-to-GDP ratio through the interest rate differential and ii) the education pertaining to the
efficiency of labor alongside experience and morbidity. We have applied our methodology to the context of Senegal.
The total losses associated with non-communicable diseases over the period 2015--2035 amount to US$ 23 billion.
Without taking into consideration the influence of diseases on net capital inflows-to-GDP ratio, total losses will be
underestimated by 2.63 %. Without taking account of education in the earning function, total losses will be
overestimated by 2.54 %.
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1 Introduction
Non-communicable diseases (NCDs) are the leading cause of death around the world. They
were responsible for 38 million (68 %) of the world’s 56 million deaths in 2012 (WHO, 2014).
These deaths occur more in low- and middle-income countries. Apart from the pain and suffer-
ing that these conditions impose on sick individuals, they generate an enormous macroeconomic
burden. During the period of 2011–2025, cumulative economic losses caused by NCDs under
a “business as usual” scenario in low- and middle-income countries have been estimated to
stand at US$7 trillion (Bloom et al., 2011; WHO, 2014). NCDs are expected to affect economic
outcomes through two main channels. First, NCDs reduce effective labor supply through mor-
tality and morbidity. Second, a fraction of the annual NCDs-related medical costs is financed
from savings, thereby reducing the ressources that should have been devoted to investment in
physical capital.
The approaches to estimating the economic impact of chronic diseases in the literature can
be classified into three main categories (Abegunde and Stanciole, 2006). The first is the cost
of illness method employed by the majority of study on economic impact of diseases. The
impact is obtained by summing the direct and the indirect cost. Direct cost consists of medical
costs (service fees, overhead costs, drugs) and non-medical costs (transportation, supplemental
foods). Indirect cost includes patients’ income losses due to morbidity and premature death.
The second approach estimates the value of lost economic welfare (VLW) based on the value
of statistical life and the disability-adjusted life years (DALYs). In this approach, the authors
utilize the value of a statistical life approach in order to value disability-adjusted life years
(DALYs), which captures both mortality and morbidity due to a disease in one metric (Alkire et
al., 2015). The common drawback of these two first approaches is that no economic adjustment
mechanisms are considered, including the substitution of labor lost due to an illness by capital
or other workers (Bloom et al., 2018). The last approach consists of assessing the impact of
diseases on the GDP. This approach is applied through the utilization of econometric analysis
or simulation analysis. The econometric analysis starts with the Solow standard model and
adds to the regressor the prevalence of diseases. The simulation models, also called Value of
lost Output (Alkire et al., 2015), measure the macroeconomic impact of diseases by comparing
the level of GDP in the situation without diseases and the situation in which diseases occur.
Our study falls into the category of simulation approaches.
Several models have been developed in the existing literature in order to evaluate the macroe-
conomic burden of these diseases. All these models build upon the traditional growth model
of Solow (1956). They differ from each other in the modeling of effective labor and dynamic of
physical capital. Evaluating the impact of AIDS on the GDP of Tanzania, Cuddington (1993)
adds to the labor supply the efficiency of labor, which accounts for morbidity through the loss of
productivity due to illness and human capital through the experience of workers. The dynamic
of physical capital takes into account both net capital flows and the national saving, which can
be reduced by healthcare expenditures. The model of Cuddington (1993) has three principle
drawbacks. First, human capital is measured only by the experience of workers despite the im-
portance of the level of education for the human capital, as suggested by the earning function of
Mincer (1974). Second, the model assumes that the net capital flow is independent of diseases.
However, the disease, by influencing both physical capital stock and the aggregate output, also
influences capital productivity and, in turn, the interest rate differential. Since the interest
rate differential is a determinant of net capital flows, it is clear that the net capital inflows-to
GDP ratio is influenced by NCDs. Third, Cuddington (1993) did not present an explicit way
that permits the approximation of labor supply in the counter-factual situation. The model
EPIC developed by Abegunde and Stanciole (2006) and Bloom et al. (2013), applicable to
NCDs, takes into account mortality and provides a way to approximate the labor supply in the
counter-factual situation. For physical capital, savings is expected to be reduced by the direct
medical cost. We can point out three main drawbacks of the EPIC model. The model does not
account for morbidity, human capital and the capital flows. Bloom et al. (2018) improved the
EPIC model by accounting for the two first drawbacks of the EPIC model, which are morbidity
and human capital accumulation. However, the net capital inflows and the fact that they are
influenced by NCDs are ignored.
In this paper, we extend the model of Cuddington (1993) by taking into account the fact
that diseases affect the net capital inflows-to-GDP ratio through the interest rate differential.
Among the channels through which NCDs can affect the GDP, the channel of the investment
rate—sum of savings rate and net capital inflows-to-GDP ratio—is badly taken into account in
existing models. The pioneer model of Cuddington (1993) considers that only the savings rate
is influenced by the disease, implying that the net capital inflows-to-GDP ratio is independent
of diseases. In other models, Abegunde and Stanciole (2006) and Bloom et al. (2018) consider
that the savings rate is influenced by NCDs and maintain the assumption of closed economy of
Solow (1956). These assumptions are particularly inappropriate due to the fact that the low-
and middle-income countries that are most affected by NCDs have a net capital inflows-to-GDP
ratio that represents a significant part of the investment rate. For instance, Cuddington (1993)
noted in the case of Tanzania that the investment rate was roughly 21%, which for 10% of
the foreign saving rate. In the context of Senegal, we have noted an investment rate of 25.35
%, including 15.35 % of the net capital inflows-to-GDP ratio. In our model, we have pushed
further the considerations of the Cuddington (1993) model, which establishes links between
diseases, physical capital stock, and aggregate output. These links imply that the net marginal
product of capital and thus the real interest rate differential is influenced by the NCDs, which
is a determinant of the net inflows-to-GDP ratio (Ndiaye et al., 2017). We have applied our
methodology in the context of Senegal and estimated the economic burden of six selected chronic
diseases (chronic obstructive pulmonary disease, ischaemic heart disease, ischaemic stroke, lung
cancer, larynx cancer, and cavity cancer) over the period 2015-2035.
The paper is organized as follows. Section 2 proposes a new model that builds upon the
model of Cuddington (1993) but additionally accounts for i) the fact that the diseases affect
the nets capital inflows-to-GDP ratio through the interest rate differential and ii) the education
in the efficiency of labor alongside experience and morbidity. Section 3 applies the model to
the context of Senegal. The conclusion is presented in the section 4.
2 Model
This model quantifies the economic burden of a particular disease as the difference in GDP
between two scenarios. In the status quo scenario, the existing NCDs in the economy affect the
aggregate output through the effective labour supply and accumulation of physical capital. In
the counter-factual scenario, the disease is eliminated from the beginning of the time period.
As in most of the previous works (Cuddington, 1993; Abegunde and Stanciole, 2006; Bloom et
al., 2013, 2015; Alkire et al., 2015; Bloom et al., 2018), we assume complete elimination of the
disease of interest with zero cost of intervention.
2.1 Production function
Aggregate output, Yt, is assumed to be produced using Cobb-Douglas technology with constant
returns to scale :
Yt = AtK
α
t E
1−α
t (1)
where Et represents effective labor supply, Kt the capital stock, At the total factors productivity,
and α the elasticity of aggregate output with respect to physical capital stock. The parameter
At can be seen as a scale factor that is adjusted to fit the projected data obtained from an
external source.
The first channel through which the disease acts on aggregate output is its adverse effect on
the components of effective labor supply: health, experience level, education level, and size of
the labor supply. These considerations are incorporated in the following expression of effective
labor supply:
Et =
64∑
i=15
(1− ziai,t)hi,tLi,t (2)
where ai,t represents the cohort-specific prevalence rate of individuals at age i, Li,t the number
of workers of age i at time t, and zi the fraction of the work year loss per disease-stricken worker
as a result of the absence or reduced productivity on the job. For simplicity, we measure1 zi
by the disability weight used in the calculation of the Years Lost due to disability (YLD).
The parameter hi,t represents the human capital, and hence the productivity level of laborers
of age i without the disease of interest. Average human capital is adversely affected as the
worsening disease of interest shifts the age structure in favor of younger, both less-experienced
workers and less-educated workers. Based on the earning function of Mincer (1974), we add the
education to the experience—which is already only taken into account in Cuddington (1993)—
in the human capital as follows:
hi,t = exp
[
ρSi,t + η1(i− 15) + η2(i− 15)
2
]
(3)
where ρ is the semi-elasticity of human capital with respect to years of education (Si,t) and η1
and η2 the semi-elasticities of human capital with respect to experience of the workforce (i−15)
and the experience of the workforce squared (i− 15)2 respectively.
In the presence of the disease of interest (status quo scenario) and neglecting the migratory
balance, the evolution of the number of workers in the status quo scenario is given by
Li,t ≈ Li−1,t−1(1− di−1,t−1) (4)
where di,t is the overall mortality rate of age group i.
Denoted by dmi,t, the mortality rate of population in age group i is due to the disease of
interest and by d−mi,t the overall mortality rate due to causes other than the disease of interest.
Considering that the product d−mi,t d
m
i,t is almost zero, we write as in Bloom et al. (2018) that
(1− di,t) ≈ (1− d
−m
i,t )(1− d
m
i,t) (5)
Following Bloom et al. (2018), we can approximate the counter-factual2 number Li,t of workers
of age i at time t by
Li,t ≈ Li,t
min{t,i}∏
j=1
(1− dmi−j,t−j)
−1 (6)
1In fact zi does not necessarily lie between 0 and 1 because the loss may be not only in the disease victim’s
labor but also in the labor of others, such as the diseased victim’s spouse (Cuddington, 1993). The author
sets a plausible value of z through the following simple calculation: if adult AIDS patients live approximately
one and a half years but are absent from work for 286 days, the productivity loss can easily reach 50 percent
even if the patients and their family members are fully productive on all the other days. Focusing only on the
productivity loss of patient and following how Cuddington (1993) found a rough order of magnitude for z in the
case of AIDS-stricken workers, we assume that the annual proportion of labor loss per disease-stricken worker
as a result of absence or reduced productivity on the job zi is equal to disability weight.
2 Hereafter, an overbar indicates that the corresponding variable refers to the counter-factual scenfario
2.2 Physical capital accumulation
We consider in the manner of Cuddington (1993) that in addition to domestic saving, capital
accumulation may be financed by foreign capital inflows. This assumption is important in the
context of developing countries due to the fact that they have a net capital inflows-to-GDP ratio
that represents a significant part of the investment rate. In this framework, physical capital
accumulation is given by
Kt+1 = Yt − Ct − χmtatLt + ENt + (1− δ)Kt (7)
where Yt represents the aggregate output measured by GDP, Ct the consumption, mt the
annual disease-related medical costs per patient, at the prevalence of disease in the population
Lt, atLt the number of patients, ENt the net capital inflows, and χ the fraction of the annual
disease-related medical costs that is financed by savings, δ is the rate of depreciation. Assume
that the consumption Ct represents a fraction ct of the aggregate output, which is the same
in the both scenarios. Under this assumption, the counter-factual savings rate is given by
st = 1− ct = 1− ct. In addition, the net capital inflows-to-GDP ratio τt =
ENt
Yt
is assumed to
be determined by the interest rate differential as in the appendix of Ndiaye et al. (2017).
τt = µt
(
α
Yt
Kt
− δ − r∗
)
with µt > 0 (8)
where r∗ represents the international interest rate. This relation (8) permits the release of the
the assumption of independence between the net capital inflows-to-GDP ratio and disease made
by Cuddington (1993). Indeed, since NCDs affect both physical capital and aggregate output,
it is obvious that they also affect the net marginal product of capital and therefore the net
capital inflows-to-GDP ratio. Thus, the dynamic of physical capital (7) is rewritten as follows:
Kt+1 =
[
st + µt
(
α
Yt
Kt
− δ − r∗
)]
Yt + (1− δ)Kt (9)
where st represents the status quo savings rate, which is defined as follows:
st = 1−
Ct + χmtatLt
Yt
In addition to its impact on the number of workers, elimination of the disease also improves
the dynamics of capital accumulation. To characterize the latter, we assume as in the previous
works (Cuddington, 1993; Abegunde and Stanciole, 2006; Bloom et al., 2013, 2015; Alkire et
al., 2015) that the elimination of this disease is done without cost. The dynamic of physical
capital is given by
Kt+1 = Y t − Ct + EN t + (1− δ)Kt (10)
Assuming that the consumption Ct represents a fraction of the aggregate output, which is the
same in the both scenarios (ct = ct), and that At, α, and µt are independent of disease, the
dynamic of counter-factual physical capital is rewritten as follows:
Kt+1 =
[
st + µt
(
α
Y t
Kt
− δ − r∗
)]
Y t + (1− δ)Kt (11)
where
st = st +
χmtatLt
Yt
and K0 = K0
From this equation (11), one remarks that the counter-factual savings rates are always higher
than the status quo savings rates (st > st). This comparison is not systematic for the net
capital inflows-to-GDP ratio except for the year of the eradication of the disease for which
τ 0 > τ0. The position of the counter-factual net capital inflows-to-GDP ratio compared to
status quo net capital inflows-to-GDP ratio for the next years depends on the extent to which
production is affected by NCDs compared to the stock capital.
Our model builds upon the model of Cuddington (1993), as it adopts a similar specification
for the aggregate output and takes into account the net capital inflows in the dynamics of
physical capital. However, unlike the model of Cuddington (1993), our model allows us to
account for i) the fact that the diseases affect the net capital inflows rate through the interest
rate differential and ii) variations in human capital for workers in different age groups due
to both education and experience. This model also sets itself apart from other models in
the literature (Abegunde and Stanciole (2006) and Bloom et al. (2018)) with regard to the
taking into account the net capital inflows-to-GDP ratio, which represents a significant part of
the investment rate in low- and middle-income countries, which are the most affected by the
diseases, especially NCDs.
3 Application for Senegal
3.1 Data sources
For aggregate output, α is set to one-third (e.g. Ndiaye et al., 2017), parameters ρ, η1 and η2
come from Echevin and Murtin (2009) and zi come from WHO (2018). For physical capital
accumulation, χ and m are provided by the survey on the cost of disease in Senegal conducted
by Consortium pour la Recherche Economique et sociale for evaluating the economic cost of
main smoking-related diseases. This survey provides information regarding the medical and
non-medical costs for patient, his family and the government. It concerns a convenience sample
of 14 senegalese public hospitals on the basis of the level of healthcare service provided and the
geographical areas. Three were national hospitals and eleven were provincial hospitals. The
survey has collect information from 2001 patients aged 18+ years discharged and diagnosed
with any of the six diseases of interest from these hospitals. Following Berlemann and Wes-
selho¨ft (2012), initial capital stock is obtained by K2015 =
eλˆ
δ+βˆ
, where βˆ and λˆ come from
the regression ln(It) = λ + β.t + ǫ over the period 2015 (t = 0) – 2035 (t = 20); s and τ are
from public institution for economic prevision of Senegal and δ si set to 0.4 (e.g. Abegunde and
Stanciole, 2006). Mortality and prevalence rates are from IHME (2017) and GDP from IFs
(2018).
3.2 Results of simulation
Table 1 presents a summary of the impact of NCDs on the rate of investment through the
savings rate and the rate of net capital inflows. We report results for the tree diseases for which
these parameters have changed. With regard to the rate of savings, over the whole period of the
study and for all diseases the counterfactual savings rate is higher than the status quo savings
rate. This comes from the fact that in absence of the disease, the fraction of the direct medical
cost which should be financed out of saving will be now used for investment in physical capital.
For the two most costly diseases (IHD and COPD), the average of counterfactual savings rates
is 10.21 % compared to 10 % in a status quo situation. For Ischemic stroke, the average
of counterfactual savings rates is 10.06 %. With regard to net capital inflows-to-GDP ratio,
the first years after the eradication of diseases are characterized by gains of productivity of
physical capital compared to the status quo situation. This results in an increase of net capital
inflows-to-GDP ratio which supports the positive effect of the elimination of the disease on the
savings rate. For 2015, counterfactual net capital inflows rates are respectively 15.56 %, 15.55%
and 15.38 % for IHD, COPD and IS compared to 15.35 % in status quo situation. But this
capital productivity gain in the counter-factual situation compared to the status quo situation
disappears over time. In 2035, counter-factual net capital inflows rates are respectively 15.30%,
15.27% and 15.32% for IHD, COPD, and IS compared to 15.35% in status quo situation. On
average over the period from 2015 to 2035, net capital inflows-to-GDP ratio are 15.38 % for
IHD and 15.34% for COPD and IS. So, the average net capital inflows-to-GDP ratio for the
IHD in the counter-factual situation is higher than the status quo net capital inflows-to-GDP
ratio. The opposite is true for the COPD and IS.
The combination of the effects of the elimination of the disease on the savings rate and
the net capital inflow rate gives the effect of the elimination on the investment rate. In 2015,
the counter-factual investment rates are respectively 25.82% of 25.80 % and 25.46% for IHD,
COPD and IS compared to status quo investment rate of 25.35%. In 2035, the counterfactual
investment rates are respectively 25.46 %, 25.45 % and 25.38 % for IHD, COPD and IS compared
to the statu quo investment rate of 25.35%. On average over the period from 2015 to 2035,
the investment rates are respectively 25.58 %, 25.55 % and 25.40% for IHD, COPD and IS.
Thus, the counterfactual average investment rate for IHD, COPD, and IS are higher than the
status quo investment rate. This means that, on average, the positive effect of the elimination
of the disease in the savings rate over the period 2015-2035 and the positive effect of gains in
physical capital productivity on the net capital inflows-to-GDP ratio right after the elimination
of diseases outweighs the negative effect of the loss of physical capital productivity on the net
capital inflows-to-GDP ratio a few years after their eliminations.
Table 1: Estimates of effect of some conditions on the saving rate, net capital
inflows-to-GDP ratio and investissement rate
Saving rate s (%) Net capital inflows τ (%) Investment i = s+ τ (%)
IHD COPD IS IHD COPD IS IHD COPD IS
Status quo 10.00 15.35 25.35
Estimated in 2015 10.25 10.25 10.08 15.56 15.55 15.38 25.82 25.80 25.46
Estimated in 2035 10.16 10.17 10.05 15.30 15.27 15.32 25.46 25.45 25.38
Average 2015-2035 10.21 10.21 10.06 15.38 15.34 15.34 25.58 25.55 25.40
The table 2 summarizes the effect of the six diseases of interest on GDP in our model. It also
compares these results with those obtained with the assumption of the independence between
the net capital inflows-to-GDP ratio and disease of interest and those obtained when the human
capital is due only to experience (Cuddington, 1993). In 2015, the estimated loss in GDP from
the six groups of diseases are US$246.69 million (constant 2011 $). These losses represent 1.42
% of GDP. These losses will increase over time and will reach US$2242.07 million (constant
2011 $) in 2035 for the six diseases. These economic burden will represent 3.73 percent of GDP
in 2035.
When we ignore the fact that diseases affect the net capital inflows-to-GDP ratio, on average,
the Senegal will annually lose US$1068.65 million over the period compared to US$1093.74
million when the influence of diseases on the net capital inflows-to-GDP ratio is taken into
account. When we ignore the fact that diseases affect the net capital inflows-to-GDP ratio,
undiscounted cumulative losses associated with these six conditions is US$22441.59 million
Table 2: Estimates of GDP loss due to cardiovascular diseases, chronic respiratory diseases,
cancer conditions over the period 2015–2035 in 2011 $US (million)
Our model∗ τ = τ = 15, 35 ρ = 0
Estimated GDP loss in 2015 246.69 246.69 253.43
(1.42)
Estimated GDP loss in 2035 2242.07 2262.70 2312.76
(3.73)
Average annual loss in GDP 1093.74 1068.65 1125.55
(2.9)
Accumulated GDP loss (2015-2035) 22968.59 22441.59 23636.64
∗: ()=% of GDP
over the period 2015-2035 compared to US$22968.59 million when the influence of diseases
on the net capital inflows-to-GDP ratio is taken into account. So, we can remark that the
consequence of neglecting the influence of diseases on the net capital inflows-to-GDP ratio is an
under-estimation of the total economic burden of selected diseases in this case of study. This
consequence come from the fact that the positive effect of gains in physical capital productivity
on the net capital inflows-to-GDP ratio in the first years of the elimination of the selected
diseases outweighs the negative effect of the loss of physical capital productivity on the net
capital inflows-to-GDP ratio a few years after their eliminations.
When the hypothesis according to which the human capital is due only to experience as in
Cuddington (1993) is made, the differences in the results with our situation are included in table
2. So, we redid the estimations with a semi-elasticity of human capital with respect to years
of schooling equals to zero in both scenarios. When we ignore the role of education in human
capital, on average, the Senegal will annually lose US$1125.55 million over the period compared
to US$1093.74 million when the role of education in human capital is taken into account. When
we ignore the role of education in human capital, on average, undiscounted cumulative losses
associated with these six conditions is US$23636.64 million over the period 2015-2035 compared
to US$22968.59 million when the role of education in human capital is taken into account. So,
we can remark that the consequence of neglecting the role of education is an over-estimation
of economic burden of selected diseases in the case of Senegal. This consequence come from
the fact that the diseases of interest shift the age structure in favor of younger (more-educated
workers) and in disfavour of older (less-educated workers) in the case of Senegal.
Undiscounted cumulative losses associated with these six groups of disease is US$22968.59
million over the whole period (2015 to 2035). Among these diseases, IHD, COPD and IS, are
the three most costly with US$11682.35 million, US$8759.29 million and US$1956.96 million
respectively. On average, Senegal will annually lose US$1093.74 million over the period. These
economic burden represent 3.73 percent of GDP in 2035.
4 Conclusion
This paper proposes a model that quantifies the economic burden of a particular disease as
the difference in GDP between two scenarios: a counter-factual scenario in which the disease is
eliminated from the beginning of the time period and a status quo scenario with the presence
of the disease. The model builds upon the Solow-style model of Cuddington (1993) while addi-
tionally accounting for i) the fact that the diseases affect the nets capital inflows-to-GDP ratio
through the interest rate differential and ii) the education in the efficiency of labor alongside of
experience and morbidity. We apply our approach to calculate the economic impact of selected
NCDs. The estimated loss in national income in Senegal from the six diseases of the study are
US$246.69 million (constant 2011 $). These losses represent 1.42% of the GDP in 2015 and
will reach US$2242.07 million (constant 2011 $) in 2035 or 3.73 % of the GDP. Undiscounted
cumulative losses between 2015 and 2035 will be US$22968.59 million (constant 2011 $) and
the average year loss over this period is US$1093.74 million (constant 2011 $). Losses from
ischemic heart disease, COPD, and stroke are 0.68 %, 0.64 %, and 0.10 % of GDP in 2015 and
1.92 %, 1.38 %, and 0.32 % in 2035.
The present study has several drawbacks. First, the incorporation of education is done by
supposing that its level is the same in the both scenarios. Demographic change will probably
affect this education level. Second, we do not express the human capital in the dynamic equation
like physical capital. Doing so, we do not take into account the impact of treatment cost on
this human capital.
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